A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

BACKGROUND: Hepatitis is a common adverse effect of antituberculosis drugs. Silymarin prevented drug-induced hepatoxicity in animals with anti-oxidative mechanisms but its effect in human has been unknown. We aimed to evaluate the efficacy of silymarin for preventing antituberculosis-drug induced li...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Complement Altern Med
Main Authors: Luangchosiri, Chote, Thakkinstian, Ammarin, Chitphuk, Sermsiri, Stitchantrakul, Wasana, Petraksa, Supanna, Sobhonslidsuk, Abhasnee
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580123/
https://ncbi.nlm.nih.gov/pubmed/26400476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-015-0861-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados